ライフサイエンスコーパス: differentiation antigen

1 ase (PAcP) is a prostate epithelium-specific differentiation antigen.

2 ase (PAcP) is a prostate epithelium-specific differentiation antigen.

3 ase (PAcP) is a prostate epithelium-specific differentiation antigen.

4 nduced expression of GpIIb, a megakaryocytic differentiation antigen.

5 endocrine status, hypoxia, and oncofetal and differentiation antigens.

6 otic expression plasmids encoding melanocyte differentiation antigens.

7 lass I-restricted epitopes of two melanocyte differentiation antigens.

8 CD8+ T cell precursors specific for melanoma differentiation antigens.

9 s, albeit with a loss of tolerance to normal differentiation antigens.

10 tumor antigens are normal, nonmutated tissue differentiation antigens.

11 TSC1 or TSC2 gene function express melanoma differentiation antigens.

12 ns are nonmutated, poorly immunogenic tissue differentiation antigens.

13 and as a ligand for the CD21 and CD11b/CD11c differentiation antigens.

14 and gp75, are well-characterized melanocyte differentiation antigens.

15 clonal antibodies directed against leukocyte differentiation antigens.

16 Thymocyte differentiation antigen 1 (Thy1) was identified as a spe

17 , CD45, Lys76, Ly(-6c) and Ly(6c), thymocyte differentiation antigen 1, and discoidin domain receptor

18 ed to expand the marrow immature granulocyte differentiation antigen-1 cell pool and demonstrated few

19 y, recovery of the marrow mature granulocyte differentiation antigen-1 cell population after E. coli

20 n, and expansion the of immature granulocyte differentiation antigen-1 precursor cell population.

21 antigen-1 was induced in sorted granulocyte differentiation antigen-1, stem cell antigen-1' cells by

22 inhibited by an antibody against cluster of differentiation antigen 14 (CD14), an adhesion molecule

23 sulting in the down-regulation of cluster of differentiation antigen 4 (CD4) and major histocompatibi

24 ic acid-inducible gene-I (RIG-I) or melanoma differentiation antigen 5 and suppressed the downstream

25 n the intracellular adapter molecule myeloid differentiation antigen 88 (MyD88), which is required fo

26 ce deficient in the adaptor molecule myeloid differentiation antigen 88 (MyD88), which is required no

27 immunization of mice against the melanocyte differentiation antigen, a tyrosinase-related protein (T

28 directed against overexpressed self-derived differentiation antigens after a nonmyeloablative condit

29 ese antigens are mainly melanoma/ melanocyte differentiation antigens, although mutated intracellular

30 The role of CD4 on immature MK as a differentiation antigen and/or receptor for the human im

31 Many of these antigens are non-mutated differentiation antigens and are expressed by virtually

32 other fusion oncoproteins, myeloid-specific differentiation antigens and minor histocompatibility an

33 Differentiation antigens are prototypes of these self an

34 Self-antigens, in the form of differentiation antigens, are commonly recognized by the

35 roach was demonstrated using viral and self-(differentiation) antigens as models.

36 responses, depending on the stage of B cell differentiation, antigen binding affinity, and duration

37 The murine B-lymphocyte differentiation antigen BP-1/6C3 has been identified as

38 ids encoding xenogeneic orthologues of tumor differentiation antigens can break immune ignorance and

39 single cells expressing the mature leukocyte differentiation antigen CD11b can also incorporate the t

40 or for IgG (Fc gamma RI/CD64) and the B-cell differentiation antigens CD19 and CD37.

41 -bound peptides from two leukemia-associated differentiation antigens; CD20 and the previously undesc

42 4.14.5; DPP IV), also known as the leukocyte differentiation antigen CD26 when found as an extracellu

43 cted against the cell surface myelomonocytic differentiation antigen CD33.

44 aries similar to those observed in the human differentiation antigen CD69.

45 immunoblastic lymphomas, with loss of B-cell differentiation antigens, clonal immunoglobulin heavy ch

46 CD14 is a monocyte differentiation antigen expressed by myeloid-derived cel

47 antigen receptor (CAR) specific for CD19, a differentiation antigen expressed in B cells and B linea

48 Nonmutated tissue differentiation antigens expressed by tumors are attract

49 er recombinant DNA vaccines targeting tissue differentiation antigens expressed by tumors.

50 nt and synthetic vaccines that target tissue differentiation antigens expressed by tumors.

51 Analysis of cytokine and differentiation antigen expression in human natural kill

52 CD8(+) T-cell responses against the melanoma differentiation antigens gp100 and tyrosinase-related pr

53 ce immune responses to five mouse melanocyte differentiation antigens, gp100, MART-1, tyrosinase, and

54 vity is essential for recruitment of myeloid differentiation antigen (Gr-1)-positive BMDCs, whereas V

55 oclonal antibodies that target hematopoietic differentiation antigens have been developed to treat he

56 in the expression of the cortical thymocyte differentiation antigen HTA 1 were derived from the T-ce

57 0% stained positively for the ED2 macrophage differentiation antigen, identifying them as perivascula

58 m untreated patients and increases monocytic differentiation antigens in some.

59 NI-1 cells expressed several MC differentiation antigens, including tryptase, Kit, and a

60 Immunohistochemical expression of melanocyte differentiation antigens, including tyrosinase-related-p

61 CD73, originally defined as a lymphocyte differentiation antigen, is thought to function as a cos

62 gnated Mndal (for MNDA-like, myeloid nuclear differentiation antigen-like), was absent in the suscept

63 Vaccine strategies targeting tissue differentiation antigens may be valuable in cancers aris

64 leads to increased expression of melanocyte differentiation antigens (MDA).

65 r/testis antigen, NY-ESO-1, and the melanoma differentiation antigen, Melan-A by human DC subsets.

66 s led to the recognition of a new melanocyte differentiation antigen, Melan-A(MART-1).

67 e CCS/MSP included those encoding melanocyte differentiation antigens, MITF, SOX10, ERBB3, and FGFR1.

68 Reduced levels of human myeloid nuclear differentiation antigen (MNDA) gene transcripts have bee

69 s, including gp100 and TRP1 (melanoma tissue differentiation antigens), NY-ESO-1 (cancer/testis antig

70 A recently described breast tissue differentiation antigen, NY-BR-1, is expressed in >80% b

71 Cells expressing differentiation antigens of mature NK cells (CD56, CD16,

72 w melanoma-associated antigens that is not a differentiation antigen or a mutated protein.

73 and stromal cells and, subsequently, myeloid differentiation antigen-positive (Gr-1(+)) myeloid cell

74 TCR, CD3, and CD4, but little or no Thy-1, a differentiation antigen present on the great majority of

75 Mesothelin is a differentiation antigen present on the surface of ovaria

76 erse processes including cell-cycle control, differentiation, antigen presentation, and the stress re

77 le tumor types-transcriptional regulation of differentiation, antigen receptor signaling, tyrosine ki

78 inase family proteins are well characterized differentiation antigens recognized by antibodies and T

79 ogically normal intestine but also expressed differentiation antigens required for normal lymphoid ho

80 only to one other known protein, the T cell differentiation antigen Rt6.

81 mmunotherapy to break tolerance against self-differentiation antigens shared by tumors.

82 Mesothelin is a tumor differentiation antigen that is highly expressed in many

83 trategy to search the dbEST database to find differentiation antigens that are expressed by cancers a

84 Examination of cell differentiation antigens that are up-regulated in FR(+)

85 active immunization against a relevant tumor differentiation antigen, the brown locus protein gp75.

86 , in variable proportions, all other NK cell differentiation antigens; the second subset expressed on

87 -primed memory T cells recognized melanocyte differentiation antigens TRP-2/DCT and gp100 and persist

88 Like other melamona differentiation antigens, TRP-2 was only expressed in me

89 isting of residues 180-188 of the melanocyte differentiation antigen tyrosinase-related protein (TRP)

90 tricted CD4+ TCR specific for the melanocyte differentiation antigen tyrosinase-related protein 1 (Ty

91 monoclonal antibody TA99 targeting melanoma differentiation antigen tyrosinase-related protein-1 (Ty

92 investigate immune responses to a melanocyte differentiation antigen, tyrosinase-related protein 1 (o

93 class II-restricted processing of melanocyte differentiation antigen, tyrosinase-related protein 1 (T

94 In this paper we identify a normal tissue differentiation antigen, tyrosinase-related protein 2 (T

95 Two proteins (caldesmon and myeloid nuclear differentiation antigen) were only weakly expressed in l

96 odel of tolerance maintained to a melanocyte differentiation antigen where tolerance can be broken by

97 Increased expression of PSMA, a differentiation antigen with folate hydrolase activity,

98 Targeting the CD33 differentiation antigen with gemtuzumab ozogamicin was t